InflaRx N.V. (IFRX) Reaches $2.89 52-Week Low; Aqr Capital Management Raised Lancaster Colony (LANC) Holding By $5.97 Million

The stock of InflaRx N.V. (NASDAQ:IFRX) hit a new 52-week low and has $2.63 target or 9.00% below today’s $2.89 share price. The 8 months bearish chart indicates high risk for the $75.00 million company. The 1-year low was reported on Jul, 19 by Barchart.com. If the $2.63 price target is reached, the company will be worth $6.75M less. The stock decreased 8.01% or $0.2514 during the last trading session, reaching $2.8886. About 3.37M shares traded or 98.55% up from the average. InflaRx N.V. (NASDAQ:IFRX) has risen 20.54% since July 19, 2018 and is uptrending. It has outperformed by 16.11% the S&P500. Some Historical IFRX News: 29/03/2018 – lnflaRx Full Year 2017 Financial & Operating Results; 17/05/2018 – InflaRx 1Q Loss EUR10.3M; 29/03/2018 – InflaRx Full Year 2017 Financial & Operating Results; 08/03/2018 – INFLARX ANNOUNCES FIRST PATIENT ENROLLED IN PHASE llB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA; 17/05/2018 – INFLARX NV – CASH POSITION APPROXIMATELY US$137 MLN (EUR 115 MLN) AS OF MARCH 31, 2018; 08/05/2018 – INFLARX N.V. REPORTS CLOSING OF PRIMARY, SECONDARY OFFERING; 03/05/2018 – INFLARX PRIMARY, SECONDARY OFFERINGS PRICES AT $34.00 PER SHARE; 17/05/2018 – InflaRx 1Q Loss/Shr EUR0.04; 08/03/2018 InflaRx announces first patient enrolled in Phase IIb trial with lead candidate IFX-1 in Hidradenitis Suppurativa; 08/05/2018 – InflaRx N.V. Announces Closing of Primary and Secondary Offering of Common Shrs

Aqr Capital Management Llc increased Lancaster Colony Corp (LANC) stake by 24.29% reported in 2019Q1 SEC filing. Aqr Capital Management Llc acquired 38,281 shares as Lancaster Colony Corp (LANC)’s stock declined 5.64%. The Aqr Capital Management Llc holds 195,893 shares with $30.63M value, up from 157,612 last quarter. Lancaster Colony Corp now has $4.13B valuation. The stock decreased 0.44% or $0.66 during the last trading session, reaching $150.14. About 25,652 shares traded. Lancaster Colony Corporation (NASDAQ:LANC) has risen 18.13% since July 19, 2018 and is uptrending. It has outperformed by 13.70% the S&P500. Some Historical LANC News: 14/03/2018 – Lancaster Colony at Group Meeting Hosted By CL King Today; 26/04/2018 – LANCASTER COLONY CORP – HAVE INITIATIVES IN PLACE OR PLANNED FOR BOTH SHORT- AND LONG-TERM TO ADDRESS HIGHER FREIGHT AND COMMODITY COSTS; 26/04/2018 – Lancaster Colony 3Q EPS $1.00; 24/04/2018 – Lancaster Colony Short-Interest Ratio Rises 84% to 9 Days; 24/04/2018 – Lancaster Colony Volume Jumps More Than Five Times Average; 29/03/2018 – Lancaster Colony Closes Above 50-Day Moving Average: Technicals; 26/04/2018 – LANCASTER COLONY 3Q EPS $1.00, EST. $1.06; 26/04/2018 – LANCASTER COLONY CORP – POSITIONED TO RETURN TO GROWTH AND RESUME PROMOTIONAL SUPPORT FOR FROZEN GARLIC BREAD PRODUCT LINE IN COMING QUARTERS; 21/04/2018 – DJ Lancaster Colony Corporation, Inst Holders, 1Q 2018 (LANC); 20/04/2018 – Lancaster Colony Closes Below 200-Day Moving Average

InflaRx GmbH, a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology in the United States. The company has market cap of $75.00 million. The Company’s C5a is an inflammatory mediator involved in the enhancement of a variety of autoimmune and other inflammatory diseases. It currently has negative earnings. The firm is involved developing IFX-1, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and other chronic/autoimmune diseases, as well as IFX-2 for the treatment of chronic inflammation and autoimmune diseases.

More notable recent InflaRx N.V. (NASDAQ:IFRX) news were published by: Seekingalpha.com which released: “InflaRx up 6% after hours on additional IFX-1 data – Seeking Alpha” on July 18, 2019, also Finance.Yahoo.com with their article: “Hedge Funds Have Never Been This Bullish On InflaRx N.V. (IFRX) – Yahoo Finance” published on June 29, 2019, Nasdaq.com published: “Health Care Sector Update for 07/19/2019: MTP, ATRA, IFRX, JNJ, ABT, MRK, PFE, AMGN – Nasdaq” on July 19, 2019. More interesting news about InflaRx N.V. (NASDAQ:IFRX) were released by: Benzinga.com and their article: “26 Stocks Moving In Friday’s Pre-Market Session – Benzinga” published on July 19, 2019 as well as Streetinsider.com‘s news article titled: “Pre-Open Movers 07/19: (CRWD) (JCP) (MIK) Higher; (MVIS) (RRGB) (SKX) (more…) – StreetInsider.com” with publication date: July 19, 2019.

Analysts await InflaRx N.V. (NASDAQ:IFRX) to report earnings on August, 8. They expect $-0.55 earnings per share, down 358.33% or $0.43 from last year’s $-0.12 per share. After $-0.43 actual earnings per share reported by InflaRx N.V. for the previous quarter, Wall Street now forecasts 27.91% negative EPS growth.

More notable recent Lancaster Colony Corporation (NASDAQ:LANC) news were published by: Finance.Yahoo.com which released: “Is Lancaster Colony Corporation (NASDAQ:LANC) As Strong As Its Balance Sheet Indicates? – Yahoo Finance” on July 02, 2019, also Finance.Yahoo.com with their article: “Hedge Funds Have Never Been This Bullish On Lancaster Colony Corporation (LANC) – Yahoo Finance” published on June 20, 2019, Finance.Yahoo.com published: “Here’s What Hedge Funds Think About Hospitality Properties Trust (HPT) – Yahoo Finance” on June 28, 2019. More interesting news about Lancaster Colony Corporation (NASDAQ:LANC) were released by: Nasdaq.com and their article: “RSI Alert: Lancaster Colony Now Oversold – Nasdaq” published on May 31, 2019 as well as Seekingalpha.com‘s news article titled: “Lancaster Is An Emerging Leader – Seeking Alpha” with publication date: February 07, 2019.

Investors sentiment increased to 2.27 in Q1 2019. Its up 0.97, from 1.3 in 2018Q4. It improved, as 10 investors sold LANC shares while 49 reduced holdings. 57 funds opened positions while 77 raised stakes. 14.94 million shares or 4.73% less from 15.68 million shares in 2018Q4 were reported. Commonwealth Of Pennsylvania Public School Empls Retrmt System reported 0.01% stake. Renaissance Ltd Com has invested 0.1% in Lancaster Colony Corporation (NASDAQ:LANC). Gsa Capital Prns Limited Liability Partnership holds 0.05% or 3,203 shares in its portfolio. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Invest Mngmt reported 0.01% of its portfolio in Lancaster Colony Corporation (NASDAQ:LANC). Toronto Dominion Fincl Bank holds 0% of its portfolio in Lancaster Colony Corporation (NASDAQ:LANC) for 1 shares. Federated Investors Pa holds 0% or 6,271 shares. Captrust Fincl holds 162 shares. Segall Bryant & Hamill Ltd Liability Company owns 13,847 shares. Bnp Paribas Arbitrage has invested 0% of its portfolio in Lancaster Colony Corporation (NASDAQ:LANC). Fifth Third Bancorp owns 0.02% invested in Lancaster Colony Corporation (NASDAQ:LANC) for 21,916 shares. Principal Gp has 0.01% invested in Lancaster Colony Corporation (NASDAQ:LANC) for 87,376 shares. Ubs Asset Mngmt Americas Inc holds 15,384 shares or 0% of its portfolio. Stone Ridge Asset Mngmt Limited holds 0.05% of its portfolio in Lancaster Colony Corporation (NASDAQ:LANC) for 5,591 shares. Moreover, Johnson Invest Counsel has 0.03% invested in Lancaster Colony Corporation (NASDAQ:LANC). Sg Americas Securities Ltd Liability Co accumulated 0.01% or 8,210 shares.

Aqr Capital Management Llc decreased Cboe Global Markets Inc (NASDAQ:CBOE) stake by 126,843 shares to 70,492 valued at $6.70 million in 2019Q1. It also reduced Berkshire Hathaway Inc Del (BRKB) stake by 28,601 shares and now owns 2.42M shares. Manpowergroup Inc (NYSE:MAN) was reduced too.

Lancaster Colony Corporation (NASDAQ:LANC) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *